Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use-Reference-Cited by-同舟云学术

Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use

Author:

Brandow Amanda M.¹²³,Wandersee Nancy J.⁴,Dasgupta Mahua²³⁵,Hoffmann Raymond G.²³⁵,Hillery Cheryl A.⁶,Stucky Cheryl L.²⁷,Panepinto Julie A.¹²³

Affiliation:

1. Section of Pediatric Hematology/Oncology; Medical College of Wisconsin; Milwaukee WI USA

2. Medical College of Wisconsin; Milwaukee WI USA

3. Children's Research Institute of the Children's Hospital of Wisconsin; Milwaukee WI USA

4. Blood Research Institute; BloodCenter of Wisconsin; Milwaukee WI USA

5. Section of Quantitative Health Sciences; Medical College of Wisconsin; Milwaukee WI USA

6. Section of Pediatric Hematology/Oncology at University of Pittsburgh Medical Center; Pittsburgh PA USA

7. Section of Cell Biology, Neurobiology, and Anatomy; Medical College of Wisconsin; Milwaukee WI USA

Funder

American Society of Hematology

National Institutes of Health National Heart, Lung, and Blood Institute

Midwest Athletes Against Childhood Cancer and Blood Diseases Fund

Publisher

Wiley

Subject

Hematology

Link

Reference76 articles.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献